HIF1A and head and neck cancer: This laboratory is the first to show that therapeutic dose of selenium as highly effective inhibitor of both constitutively expressed HIF-1α, HIF-2α in ccRCC (Figure 3A and 6B) and hypoxia induced HIF-1α in head & neck cancer [22].